Company Profile

Wellspring Biosciences LLC
Profile last edited on: 1/25/19      CAGE: 6T0L5      UEI:

Business Identifier: Medicines for treatment of cancer
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

11119 North Torrey Pines Road Suite 125
La Jolla, CA 92037
Location: Single
Congr. District: 52
County: San Diego

Public Profile

Wellspring is organized around the discovery and development of small molecule drugs that target signal transduction networks for the treatment of cancer and other diseases. Through partnerships with academic and industry experts, the firm is translating chemical and biological insights into novel, highly targeted drugs. The team has a proven track record, having previously played important roles in the discovery and development of clinical-stage compounds for the treatment of cancer and immune-mediated inflammatory disease at pharmaceutical company Intellikine. Since early 2013, firm has had close ties to Janssen Biotech (J&J). Parent company is Araxes Pharma with principals of the firm also having close ties Kura Oncology Inc (KURA.OQ).

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2014 1 NIH $215,385
Project Title: Development of ATP-Competitive Inhibitors of KSR for the Treatment of Cancer
2013 1 NIH $225,016
Project Title: Direct Inhibition Of Mutant K-Ras For The Treatment Of Cancer

Key People / Management

  Troy Wilson -- President, CEO and Co-Founder

  Heidi Henson -- Chief Financial Officer

  Yi Liu -- Chief Scientific Officer

  Anna Nadolski -- Business Advisor

  Annette North -- General Counsel

  Matthew Patricelli

  Pingda Ren -- Senior Vice President, Chemistry

  Kevan Shokat -- Scientific Advisor